TABLE 2.

The clinicopathological characteristics of T3‐T4 GSCC patients

	All patients		Non‐LNM group		LNM group
	n = 394	%	n = 330	%	n = 64	%	P‐value
Age							.429
≥60	210	53.3	173	52.4	37	57.8
<60	184	46.7	157	47.6	27	42.2
Sex							.451
Female	12	3.0	11	3.3	1	1.6
Male	382	97.0	319	96.7	63	98.4
History of smoking							.311
No	113	28.7	98	29.7	15	23.4
Yes	281	71.3	232	70.3	49	76.6
History of alcohol drinking							.840
No	220	55.8	185	56.1	35	54.7
Yes	174	44.2	145	43.9	29	45.3
History of hypertension							.688
No	321	81.5	270	81.8	51	79.7
Yes	73	18.5	60	18.2	13	20.3
History of diabetes							.877
No	374	94.9	313	94.8	61	95.3
Yes	20	5.1	17	5.2	3	4.7
T stage							.013
T3	300	76.1	259	78.5	41	64.1
T4	94	23.9	71	21.5	23	35.9
Differentiation							.030
High	178	45.2	157	47.6	21	32.8
Moderate and Low	216	54.8	173	52.4	43	67.2
Maximum tumor diameter (MTD)							.000
≤2.0 cm	130	33.0	123	37.3	7	10.9
>2.0 cm	264	67.0	207	62.7	57	89.1
Tumor invasive depth							.000
<1.0 cm	123	31.2	118	35.8	5	7.8
≥1.0 cm	271	68.8	212	64.2	59	92.2